1. $Camtek(CAMT)$ CAMT - Camtek Ltd - midcap company performance since short breakout: -5.47%.2. $BBVA Banco Frances SA(BBAR)$ BBAR - BBVA Banco Frances SA ADR - midcap company performance since short breakout: -3.83%.3. $Snowflake(SNOW)$ SNOW - Snowflake - largecap company performance since short breakout: -2.94%.4. $Dynavax(DVAX)$ DVAX - Dynavax Technologies Corporation - smalecap company performance since long breakout: 4.68%.5. $Mineralys Therapeutics, Inc.(MLYS)$ MLYS - Mineralys Therapeutics Common Stock - smalecap company performance since long breakout: 5.42%.
Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of patients with uncontrolled or resistant hypertension. The company was incorporated in 2019 and is headquartered in Radnor, Pennsylvania.